1130 St. Nicholas Avenue
New York, New York 10032
The Herbert Irving Comprehensive Cancer Center is Columbia University ‘s organizational structure for laboratory, clinical, and population-based cancer research with a mission to “reduce the burden of cancer through scientific innovation and interdisciplinary collaboration.” The Herbert Irving Comprehensive Cancer Center (HICCC), features 12 core facilities and nine research programs that focus on cancer disparities, molecular targets, pathogenesis, survivorship, and quality of life. New York-Presbyterian Hospital, which is ranked seventh in the U.S. News & World Report rankings for 2005, provides all cancer-related patient services for the Herbert Irving Comprehensive Cancer Center.
Herbert Irving Comprehensive Cancer Center is one of only 39 National Cancer Institute designated Comprehensive Cancer Centers in the U.S. , and one of only three in the State of New York . Herbert Irving Comprehensive Cancer Center currently has over 200 members from a total of six schools at Columbia University. Current member NCI funding is more than $23 million and total peer-reviewed cancer research funding is around $90.0 million.
Herbert Irving Comprehensive Cancer Center member funding from the National Cancer Institute is currently at $23 million and peer-reviewed cancer research currently totals around $90 million. HICCC research programs include three divisions and they include: basic, disease-specific, and population based science. The center has a total of eight research programs including: Cancer Genetics and Epigenetics, Cancer Signaling Networks, Breast Cancer, Lymphoid Development & Malignancy, Prostate Cancer, Neuro-Oncology, Cancer Epidemiology, and Prevention, Control, and Disparities. The Center also manages and supports 12 shared resources (SRs), which provide services that are essential to advancements in cancer through cancer research.
HICC, in partnership with New York-Presbyterian Hospital, HICCC employs experts in surgery, hematology, medical oncology, neuro-oncology, urological oncology, radiation therapy, pathology, nursing, social work, and psychology that work together to meet the create a personalized treatment plan for each individual cancer patient.
HICCC clinical departments and divisions are: Radiation Oncology, Surgical Oncology, Urologic Oncology, Gynecologic Oncology, Hematology/Oncology, GI/Endocrine Surgery, Neuro-oncology (Brain Tumor Center), Pediatric Hematology, Pediatric Blood and Marrow Transplantation, and Pediatric Oncology.
HICCC clinicians diagnose and treat more than 3,500 new cancer cases each year, and offers access to more than 200 clinical trials. Many of HICCC’s clinical trails feature studies designed to help understand the incidence and progression of cancer, and to improve quality of life, as well as many therapeutic regimens. For additional information about clinical trials, call the Herbert Irving Comprehensive Cancer Center’s Clinical Research Management Office at (212) 305-8615.